2010 - Transplantomics and Biomarkers in Transplantation
This page contains exclusive content for the member of the following sections: TTS. Log in to view.
PREDICTING GRAFT RISK BY TRANSPLANTOMICS
3.1 - THE IMPACT OF GENOME-WIDE VARIATION IN RENAL TRANSPLANT DONORS AND RECIPIENTS ON GRAFT SURVIVAL
Presenter: Graham, Lord, London, UK
Authors: Graham Lord
THE IMPACT OF GENOME-WIDE VARIATION IN RENAL TRANSPLANT DONORS AND RECIPIENTS ON GRAFT SURVIVAL
Graham Lord, Professor of Medicine, Nephrology, Transplantation and Internal Medicine; Director of Translational Research Development and Deputy Director of NIHR Comprehensive Biomedical Research Centre; Guy’s and St. Thomas’ Hospital and King’s College London, London, UK
Graham Lord, Professor of Medicine, Nephrology, Transplantation and Internal Medicine; Director of Translational Research Development and Deputy Director of NIHR Comprehensive Biomedical Research Centre; Guy’s and St. Thomas’ Hospital and King’s College London, London, UK
Learning Objectives:
1. Understand the theory of genome-wide association scans.
2. Understand ways of analyzing the interaction of two genomes in a single patient.
3. Learn what is known about the genetics of allograft dysfunction.
Genetic interactions between donor and recipient genomes in the context of renal transplantation determine early and late renal allograft dysfunction and subsequent transplant failure. Renal transplant failure is largely genetically determined and the majority of the donor and recipient genes that cause allografts to fail are unknown. Genome wide association scans in this patient population will help us to define the genetic variation in donor and recipient genomes that determine long term renal allograft outcome and the variation in donor and recipient genomes that determine short term renal allograft dysfunction. Furthermore, we are able to discover variation in the recipient genome that correlates with end-stage renal failure.
Resolving these scientific questions will rapidly enable early translational studies of organ allocation and graft monitoring with a realistic prospect of improving patient outcomes within a relatively short timeframe.
Important Disclaimer
By viewing the material on this site you understand and accept that:
- The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
- The material is solely for educational purposes for qualified health care professionals.
- The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
- The information cannot be used as a substitute for professional care.
- The information does not represent a standard of care.
- No physician-patient relationship is being established.
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada